Clinical Trial Update: A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study completed to evaluate the effect of diltiazem on the PK of the investigational BMS-986141 in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• BMS-986141
• Diltiazem (diltiazem)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ischemic Stroke | Phase 1 | Status: COMPLETED